How should a patient with per rectal bleeding and oral ulcers be managed?

Management of Per Rectal Bleeding with Oral Ulcers

This presentation strongly suggests Behçet's disease, and you should immediately initiate topical corticosteroids for the oral ulcers while urgently pursuing colonoscopy to evaluate the rectal bleeding and determine if gastrointestinal Behçet's involvement is present.

Initial Diagnostic Approach

The combination of oral ulcers and PR bleeding is a red flag for Behçet's disease (BD), which commonly presents with mucocutaneous manifestations alongside gastrointestinal involvement. You need to:

• Examine for other BD stigmata: genital ulcers, pathergy test positivity, eye inflammation, skin lesions (erythema nodosum, acne-like lesions, papulopustular lesions)
• Urgent colonoscopy: Identify the source and severity of rectal bleeding—look for rectal ulcers with major stigmata (active bleeding, visible vessel, adherent clot) which carry high risk for severe and recurrent bleeding 1
• Assess hemodynamic stability: Check hematocrit, transfusion requirements, and comorbidities (diabetes, low albumin, poor performance status increase risk of massive bleeding) 2

Immediate Management Algorithm

For the Oral Ulcers (Mucocutaneous Disease):

Start with topical corticosteroids as first-line treatment for isolated oral ulcers 3. Additional topical options include:

• Lidocaine gel for pain relief
• Chlorhexidine for oral hygiene
• Sucralfate suspension (proven effective in RCT for oral and genital ulcers) 3

For the Rectal Bleeding:

The management depends on colonoscopy findings:

If rectal ulcers with major stigmata are identified:

• Achieve endoscopic hemostasis with epinephrine injection and bipolar probe coagulation 1
• Be aware that recurrent bleeding rates are high (approximately 42% in one series) despite initial hemostasis 1
• Patients with lower performance status, diabetes, multiple comorbidities, and low albumin require more aggressive monitoring as they're at risk for massive bleeding requiring ≥12 units transfusion 2

If simple rectal ulcers without stigmata:

• Conservative management may suffice
• No recurrent bleeding expected in this group 1

Systemic Treatment for Behçet's Disease

If BD is confirmed and mucocutaneous lesions are resistant to topical therapy, escalate systematically:

1. Colchicine: Preferred when erythema nodosum is the dominant lesion; also effective for genital ulcers in women 3

2. Azathioprine 2.5 mg/kg/day: For resistant mucocutaneous lesions and effective in preventing recurrence 3

3. For severe or refractory cases: Consider IFNα or TNFα antagonists, though reserve these for selected cases given cost and side effects 3

Critical Pitfalls to Avoid

• Do NOT use ciclosporine A if neurological involvement is suspected or present—it has neurotoxic potential in BD patients 3
• Do NOT assume all rectal ulcers are the same: Post-thrombotic/venous stasis ulcers require rest, elevation, and topical zinc; vasculitic ulcers from BD require systemic immunosuppression 3
• Do NOT delay colonoscopy: Rectal ulcers with major stigmata have high mortality risk from comorbid conditions (17% in one series) 1
• Do NOT underestimate recurrent bleeding risk: Even after successful endoscopic hemostasis, close monitoring is essential as rebleeding is common 1

Monitoring and Follow-up

• Patients requiring >12 units transfusion need longer NPO periods, extended TPN, and prolonged hospitalization 2
• Duration from bleeding to hemostasis is significantly longer in massive bleeders 2
• If endoscopic hemostasis fails or bleeding recurs, surgical options (cauterization, embolization, banding, local excision) may be necessary 4

The key is recognizing this as likely BD early, treating the oral ulcers topically while simultaneously addressing the potentially life-threatening rectal bleeding through urgent endoscopic evaluation and hemostasis.